Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Evogene Chairman Nir Nimrodi Resigns Board Seat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.365
Mkt Cap
$6.698M
52W Low
$0.25
52W High
$1.26
52W Position info
46% above low
Off High info
71% below high
Rel. Volume
Market data snapshot near publication time

EVGN sits 46% above its 52-week low of $0.25.

Summary

Evogene's chairman Nir Nimrodi resigned from the board on November 13, 2026, with no disagreement cited and no replacement named. It is the latest board departure at a company already dealing with a Nasdaq bid-price deficiency and a recently settled activist fight.


Key Events · Executive and Board Changes · EVGN

  • Chairman Resigns Board

    Nir Nimrodi notified the board on November 13, 2026 of his resignation as a member and chairman of the board of directors.

  • No Disagreement Cited

    The filing states the resignation was not related to any disagreement with the Company on operations, policies or practices.

  • No Successor Named

    The 6-K does not identify an interim or permanent chairman, leaving the board's leadership slot open.

  • Follows Recent Board Turnover

    Directors Yoshinori Oikawa and Yael Margolin resigned on September 9, 2026, and the board was reconstituted under the October 6, 2026 cooperation agreement with Pure Capital.


Analysis · EVGN · Industrial Applications And Services

The chairman of the board is gone, and the filing names no successor, leaving a board that was only just reconstituted under the October 6 cooperation agreement with Pure Capital. This comes weeks after two directors resigned on September 9 and a proxy fight ended in a settlement, marking a second wave of board turnover at a company already fighting a Nasdaq minimum-bid deficiency and burning cash. The filing says the departure is not over any disagreement, but a chairman exit at this juncture removes continuity exactly when the board is supposed to be overseeing the activist-backed reset.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.25 to $1.26. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.3646 info
Change: -$0.0455 (-11%) info
Market Cap: $6.698M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.3646 info
Change: -$0.0522 (-13%) info
Market Cap: $6.698M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.3646 info
Change: -$0.0261 (-7%) info
Market Cap: $6.698M info
EVGN
Sep 15, 2026, 5:15 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.5281
Real-time Price: $0.3646 info
Change: -$0.1635 (-31%) info
Market Cap: $6.698M info
EVGN
Sep 11, 2026, 6:31 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
9
Price at Filing: $0.4728
Real-time Price: $0.3646 info
Change: -$0.1082 (-23%) info
Market Cap: $6.698M info